The weight loss effect of Ozempic is thought to be due to the drugs ability to copy the effects of the hormone called GLP-1, which balances blood sugar levels and increases feelings of fullness
And Zepbound (tirzepatide) is one of the latest additions in the GLP-1 landscape, one specifically approved by the Food and Drug Administration (FDA) for chronic weight management
The real risk is losing behavioral momentum and making it harder to stick to your calorie goals when appetite-suppressing medication isn't actively working
Clinically, reduced iron-binding protein levels during surgery indirectly reflect impaired catalytic iron regulation during extracorporeal circulation, contributing to renal injury (83), underscoring the relevance of iron homeostasis to renal I/R pathophysiology
The main ongoing studies: REDEFINE 1 , Phase 3 obesity without T2D (results 20242025, preliminarily 25.3 %) REDEFINE 2 , Phase 3 obesity + T2D REDEFINE 3 , Phase 3 cardiovascular outcome trial (n~7000) Stand-alone clinical development of Cagrilintide is limited , Novo Nordisk is primarily investing in the CagriSema combination
